Research To Practice | Oncology Videos

Latest Episodes:

Urothelial Bladder Cancer | Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Urothelial Bladder Cancer May 31, 2023

Show notes

Featuring perspectives from Prof Sia Daneshmand, Dr Joshua J Meeks, Dr Matthew Milowsky and Prof J Alfred Witjes, moderated by Dr Arlene Siefker‑Radtke, including the following topics:

Introduction (0:00)
Current Role of Anti-PD-1/PD-L1 Antibodies in the Treatment of Non-Muscle-Invasive Bladder Cancer — Joshua J Meeks, MD, PhD (2:49)
Contemporary Management of Muscle-Invasive Bladder Cancer — J Alfred Witjes, MD, PhD (26:30)
Novel Strategies Under Investigation for Nonmetastatic Urothelial Bladder Cancer (UBC) — Sia Daneshmand, MD (48:02)
Current and Future Up-Front Management of Metastatic UBC (mUBC) — Matthew Milowsky, MD (1:12:26)
Selection and Sequencing of Therapy for Relapsed/Refractory mUBC — Arlene Siefker-Radtke, MD (1:33:25)

CME information and select publications

What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Hepatobiliary Cancers May 30, 2023

Show notes

Featuring perspectives from Dr Ahmed Omar Kaseb, Ms Blanca Ledezma, Dr Daneng Li and Ms Amanda K Wagner, including the following topics:

Introduction (0:00)
Overview of Hepatocellular Carcinoma (HCC) (3:37)
First-Line Systemic Therapy for HCC (27:37)
Therapy for Relapased HCC (41:43)
Overview of Biliary Tract Cancers (54:10)
First-Line Systemic Therapy for Biliary Tract Cancers (1:8:45)
Targeted Treatment for Biliary Tract Cancers (1:11:25)

NCPD information and select publications

Chronic Lymphocytic Leukemia | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Chronic Lymphocytic Leukemia May 25, 2023

Show notes

Featuring perspectives from Dr John N Allan, Ms Jacqueline Broadway‑Duren, Ms Corinne Hoffman and Dr Adam S Kittai, including the following topics:

Introduction (0:00)
Overview of Chronic Lymphocytic Leukemia (CLL) (5:20)
First-Line Therapy for CLL (32:06)
Use of Venetoclax in Combination with an Anti-CD20 Antibody (49:16)
Choice of BTK Inhibitor; BTK Inhibitor Toxicity (1:14:33)
Noncovalent BTK Inhibitors (1:18:53)
CAR T-Cell Therapy; Transformation (1:23:08)

NCPD information and select publications

Prostate Cancer | Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Prostate Cancer May 24, 2023

Show notes

Featuring perspectives from Dr Himisha Beltran, Dr Stephen J Freedland, Dr Fred Saad and Dr Neal D Shore, moderated by Dr Matthew R Smith, including the following topics:

Introduction (0:00)
Management Approaches for Nonmetastatic Prostate Cancer — Dr Freedland (1:45)
Optimizing the Care of Patients with Metastatic Hormone-Sensitive Prostate Cancer — Dr Saad (26:14)
Therapeutic Considerations for Patients with Newly Diagnosed Metastatic CRPC (mCRPC) — Dr Shore (51:51)
Contemporary Management of mCRPC in Patients Harboring a Homologous Recombination Repair Gene Alteration — Dr Smith (1:16:20)
Current and Emerging Strategies in the Treatment of Recurrent mCRPC — Dr Beltran (1:36:47)

CME information and select publications

Lung Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Lung Cancer May 22, 2023

Show notes

Featuring perspectives from Dr Stephen V Liu, Ms Tara Plues, Ms Jillian Thompson and Dr Anne S Tsao, including the following topics:

Introduction (0:00)
Immunotherapy for Nonmetastatic and Metastatic Non-Small Cell Lung Cancer (NSCLC) (5:47)
Future Directions — Tumor Treating Fields (37:30)
Overview of Targeted Treatment for NSCLC (53:38)
Targeted Treatment for NSCLC with an EGFR Mutation (1:10:48)
EGFR Exon 20 Insertion Mutations (1:26:35)
Targeted Treatment for NSCLC with a RET Fusion (1:37:40)
Targeted Treatment for NSCLC with a KRAS G12C Mutation (1:46:45)

NCPD information and select publications

Biliary Tract Cancers — Richard S Finn, MD May 19, 2023

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers — Facutly Presentation 2: Biliary Tract Cancers — Dr Richard S Finn

CME information and select publications

Hepatobiliary Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers May 19, 2023

Show notes

Featuring perspectives from Drs Ghassan Abou‑Alfa and Richard S Finn, including the following topics:

Introduction (0:00)
Prologue: Last Week (2:33)
Hepatocellular Carcinoma (4:37)
Biliary Tract Cancers (35:20)

CME information and select publications

Hepatocellular Carcinoma — Ghassan Abou-Alfa, MD, MBA May 19, 2023

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers — Facutly Presentation 1: Hepatocellular Carcinoma — Dr Ghassan Abou-Alfa

CME information and select publications

Breast Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Breast Cancer May 17, 2023

Show notes

Featuring perspectives from Ms Jamie Carroll, Dr Virginia Kaklamani, Dr Joyce O'Shaughnessy and Mr Ronald Stein, including the following topics:

Introduction (0:00)
ER-Positive, HER2-Negative Localized Breast Cancer — Part 1 (7:12)
ER-Positive, HER2-Negative Localized Breast Cancer —Part 2 (26:18)
ER-Positive Metastatic Breast Cancer (37:16)
Localized HER2-Positive Breast Cancer (49:27)
HER2-Positive and HER2-Low Metastatic Breast Cancer — Part 1 (1:04:09)
HER2-Positive and HER2-Low Metastatic Breast Cancer — Part 2 (1:27:00)
PARP Inhibitors (1:32:21)
Immune Checkpoint Inhibitors (1:43:32)

CME information and select publications

Cervical and Endometrial Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Cervical and Endometrial Cancer May 11, 2023

Show notes

Featuring perspectives from Ms Paula J Anastasia, Dr Michael J Birrer, Ms Jennifer Filipi and Dr Brian M Slomovitz, including the following topics: